欢迎访问WTO技术性贸易措施服务平台(商务部应对贸易摩擦工作站)

WTO技术性贸易措施服务平台(商务部应对贸易摩擦工作站)

中文标题:《受控药物和物质法》修正案附表五(加速安排三种芬太尼前体化学品和加勒比醇)(英文和法文3页)修改《受控药物和物质法》(芬太尼前体和加勒比醇)附表五的命令(英文14页,法文16页)

英文标题:Amending Schedule V to the Controlled Drugs and Substances Act (Accelerated scheduling of three fentanyl precursor chemicals and carisoprodol) (3 pages, in English and French)Order Amending Schedule V to the Controlled Drugs and Substances Act (Fentanyl Precursors and Carisoprodol) (14 pages in English, 16 pages in French)

通报时间:2025-03-14

通报号:G/TBT/N/CAN/745

通报成员:加拿大

评议截止日期:2025-05-30

拟批准日期:

拟生效日期:

覆盖产品:DrugsPhenethyl bromide (HS code: 2903999090)Propionic anhydride (HS code: 2915900090)Benzyl chloride (HS code: 2903999090)Carisoprodol (HS code: 2924199090)

内容概述:The purpose of this notification is to let members know that on February 27, 2025, Canada took swift action to temporarily control the following substances under the Controlled Drugs and Substances Act:phenethyl bromidepropionic anhydride G/TBT/N/CAN/745- 2 -benzyl chloridecarisoprodolThese substances are now being considered for longer-term control under the same Act.

“通报评议指WTO成员对其他成员通报的技术性贸易措施草案,依据《TBT协定》和《SPS协定》的原则,以对相关产品国际贸易的影响和对本国相关产业的影响为着眼点,对措施草案是否具有规则合理性、技术合理性、贸易合理性,提出批评、质疑或关注的活动。 在征求意见期间,任何机构、企业、个人都可以对于一项外国的TBT/SPS措施提出评议意见。提交给外方的评议意见将由外方相关机构审议,并做出是否采纳的回复,如果不予采纳,外方必须给出充分的理由。”
确认提交 如有疑问,请咨询0571-85786911